期刊文献+

异硫氰酸苯己酯降低U266细胞株p16基因甲基化的研究 被引量:1

Phenylhexyl Isothiocyanate Reducing U266 Cell Line Methylation Level of p16 Gene
在线阅读 下载PDF
导出
摘要 本研究探讨异硫氰酸苯己酯对p16基因高甲基化的多发性骨髓瘤U266细胞株是否有去甲基化的作用。用异硫氰酸苯己酯0、5、10μmol/L孵育U266细胞株,提取DNA备用。用亚硫酸氢盐处理正常人基因组DNA,并以此为模板进行PCR扩增。设计1组特殊荧光标记探针以构建1种检测p16基因启动子区3个CpG位点甲基化改变的芯片,特殊荧光标记探针包括1对非甲基化探针和甲基化探针,检测相邻的3个CpG位点甲基化的程度。采用基因芯片的方法,将完全未甲基化的DNA和完全甲基化的DNA混合后制成标准曲线,将U266细胞株样本处理后点在芯片上与标准曲线进行比较后得出定量检测的结果。结果表明:芯片上探针的可重复性和精确性很好,0、5、10μmol/L异硫氰酸苯己酯处理后的U266细胞株p16基因的甲基化程度分别为78.2%、61.7%、54.8%。结论:异硫氰酸苯己酯可以降低U266细胞株p16基因甲基化的程度。 This study was purposed to investigate whether phenylhexyl isothiocyanate (PHI) can reduce p16 gene methylation level or not. The myeloma U226 cell line was cultued with PHI of 0,5,10 μmol/L for 72 hours, then DNA was extracted. Hydrosulfite was used to treat the genome DNA of healthy adult, PCR amplification was carded out by using this DNA as template. The gene chip detecting rnethylation changes of 3 CpG in promoter region of p16 gene was constructed by designing a pair of probes which contain one methylated and one unmethylated probes. This pair of probes was used to detect 3 consecutive sites of CpG island in p16 gene. The standard curve was constructed by using gene chip after the methylated and unmethylated DNA were mixed at different ratio. Then treated samples of U266 cells were dotted on gene chip, obtained results were compared with standard curve to get the quantitative results. The results indicated that the probes on chip had excellent reproducible ability and precision, the methylation level of p16 gene in U266 cells treated with 0,5 and 10 μmol/L of PHI was determined as 78.2%, 61.7% and 54.8%, respectively. It is concluded that the PHI can reduce the methylation level of p16 gene in U266 cells.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第5期1060-1063,共4页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目(编号39970832) 国家自然科学基金项目(编号30600152)
关键词 异硫氰酸苯己酯 U266细胞株 P16基因甲基化 基因芯片 phenylhexyl isothiocyanate U266 cell line p16 gene methylation gene chip
作者简介 通讯作者:陈宝安,主任医师,博士生导师.电话(025)83792006.E-mail:cba8888@hotmail.com
  • 相关文献

参考文献8

  • 1Kanai Y, Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis, 2007 ; 28:2434 - 2442
  • 2Lomberk G. Epigenetics. Pancreatology, 2007; 7:396-397
  • 3Matsuda Y, Ichida T. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis. Med Mol Morphol, 2006 ; 39 : 169 - 175
  • 4Claus R, Almstedt M, Lubbert M, et al. Epigenetie treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol, 2005 ; 32:511 - 520
  • 5张嘉玲,苏秀兰.去甲基化在肿瘤治疗中的作用[J].中国误诊学杂志,2006,6(23):4531-4533. 被引量:6
  • 6Ogawa K, Hirose M, Sugiura S, et al. Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis. Nutr Cancer,2001 ; 40 : 134 - 139
  • 7Okazaki K, Yamagishi M, Son HY, et al. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl) nitros- amine. Nutr Cancer, 2002 ; 42:211 - 216
  • 8Ma X, Fang Y, Beklemisheva A, et al. Phenyhexyle isothiocyanate inhibits histone deacetylase and remodels chromation to induce growth arrest in human leukemia ceils. Int J OncoL, 2006 ; 28 : 1287 - 1293

二级参考文献10

  • 1Goffin J,Eisenhauer E.DNA methylatransferase inhibitors-state of the art[J].Ann Oncol,2002,13 (11):1699-1716.
  • 2Das PM,Singal R.DNA Methylation and cancer[J].J Clin Oncol,2004,22(22):4632-4642.
  • 3Esteller M.DNA Methylation and cancer therapy:new developments and expectations[J].Curr Opin Oncol,2005,17 (1).55-60.
  • 4Huang TH,Perry MR,Laux DE.Methylation profiling of CpG islands in human breast cancer cells[J].Hum Mol Genet,1999,8(3):459-470.
  • 5Ahluwalia A,Yan P,Hurteau JA,et al.DNA Methylation and ovarian cancer.I.Analysis of CpG island hypermethylation in human ovarian cancer using differential Methylation hybridization[J].Gynecol Oncol,2001,82(2):261-268.
  • 6Yan PS,Shi HD,Rahmatpanah F,et al.Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer[J].Cancer Res,2003,63 (19):6178-6186.
  • 7Santini V,Kantarjian HM,Issa JP.Changes in DNA Methylation in neoplasm:pathophysiology and therapeutic implications[J].Ann Inter Med,2001,134:573-586.
  • 8Silverman LR.Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome:a study of the cancer and leukemia group B[J].J Clin Oncol,2002,20:2429-2440.
  • 9Wijermans PW.Low-dose 5-aza-2'-deoxycytidine,a DNA hypomethylating agent,for the treatment of high-risk myelodysplastic syndrome:a multicenter phase Ⅱ study in elderly patients[J].J Clin Oncol,2002,18:956-962.
  • 10Issa JJ.Phase I study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2' deoxycytidine (decitabine)in hematopoietic malignancies[J].Blood,2004,103:1635-1640.

共引文献5

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部